RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,014 | -39.7% | 10,183 | -6.9% | 0.00% | – |
| Q4 2022 | $38,160 | -96.6% | 10,934 | -63.8% | 0.00% | -100.0% |
| Q3 2022 | $1,117,000 | +106.5% | 30,171 | +5.8% | 0.00% | +100.0% |
| Q2 2022 | $541,000 | -35.8% | 28,507 | -8.7% | 0.00% | 0.0% |
| Q1 2022 | $843,000 | +31.9% | 31,222 | +10.1% | 0.00% | 0.0% |
| Q4 2021 | $639,000 | +38.0% | 28,366 | +60.7% | 0.00% | 0.0% |
| Q3 2021 | $463,000 | -30.2% | 17,656 | -14.8% | 0.00% | 0.0% |
| Q2 2021 | $663,000 | -14.8% | 20,724 | -6.2% | 0.00% | 0.0% |
| Q1 2021 | $778,000 | +9.6% | 22,104 | -0.1% | 0.00% | 0.0% |
| Q4 2020 | $710,000 | -13.5% | 22,130 | +1.4% | 0.00% | 0.0% |
| Q3 2020 | $821,000 | -13.5% | 21,832 | +3.0% | 0.00% | -50.0% |
| Q2 2020 | $949,000 | – | 21,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |